The authors found that in 2023 there were 93 million CTs done on 62 million patients. The total estimated lifetime number of ...

Thanks to budget cuts, many potential insights and treatments needed to propel oncology forward will never be realized.

CHINO HILLS, CALIFORNIA / ACCESS Newswire / May 6, 2025 /SOHM, Inc. (OTC PINK:SHMN), a biotech company at the forefront of precision cellular engineering, announced today the successful development of ...

The U.S. government is preparing to make moves to get food dyes out of what we eat– a plan which may spark curiosity across ...

Breast cancer is the leading cause of cancer death among Latinas. Testing for breast density and other risk factors can save ...

NuCana plc (NASDAQ: NCNA), a clinical-stage biopharmaceutical company that focuses on significantly improving treatment outcomes for patients with cancer, announced that it has priced a registered ...

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated ...

They blamed the Massachusetts Department of Public Health, which is responsible for regulating such projects, for failing to verify that the expansion will satisfy an actual need for more cancer ...

Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer's Regorafenib drug combination significantly reduced hepatic tumor ...